Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]
Success Fee
RSS Feeds
Search

Success Fee

Success Fee

The Success Fee is a compensation formula applied at the back-end of all successfully completed agreements effectuated by our clients based on an introduction through Innovaro Pharmalicensing's Partnering Search & Profiling services.

The Success Fee will be calculated based on the formula below (in US$):

Partnering Search

  • 8% of the first million dollars US involved in the transaction
  • 6% of the second million
  • 4% of the third million
  • 2% of everything thereafter (above 3 million dollars US)

Profiling

  • 4% of the first million dollars US involved in the transaction
  • 3% of the second million
  • 2% of the third million
  • 1% of everything thereafter (above 3 million dollars US)

The Success Fee is applied by Innovaro Pharmalicensing based only on a successfully completed agreement between our client and a third party organisation introduced to the client by Innovaro Pharmalicensing. Payment shall be made to Innovaro Pharmalicensing in the same manner and time that the payments are exchanged between our client and the third party.


Partnering Search - Check how we can assist you.

What would be the Success Fee for $10,000,000 transaction?

Partnering Search

The simple answer is $320,000.

And this is how we calculate the Success Fee:

Transaction value % Success Fee
$1,000,000 8% $80,000
$1,000,000 6% $60,000
$1,000,000 4% $40,000
$7,000,000 2% $140,000
$10,000,000   $320,000

A few other examples:

Transaction value Success Fee Overall %
$10,000,000 $320,000 3.2%
$15,000,000 $420,000 2.8%
$20,000,000 $520,000 2.6%
$25,000,000 $620,000 2.48%

Profiling

And for Profiling it is $160,000.

And this is how we calculate the Success Fee in this case:

Transaction value % Success Fee
$1,000,000 4% $40,000
$1,000,000 3% $30,000
$1,000,000 2% $20,000
$7,000,000 1% $70,000
$10,000,000   $160,000

A few other examples:

Transaction value Success Fee Overall %
$10,000,000 $160,000 1.6%
$15,000,000 $210,000 1.4%
$20,000,000 $260,000 1.3%
$25,000,000 $310,000 1.24%

Frequently asked questions about Success Fee:

Do we have to pay a Success Fee on all deals that we do in the future?
No, the Success Fee is only applicable to those agreements which have been actively effectuated by an introduction to the third-party partner organisation through Innovaro Pharmalicensing services.

At what point is the Success Fee payable? Do we have to pay the Success Fee at the time we execute an agreement with the third party?
No, you would not need to pay the Success Fee at the time you execute the agreement with the third-party. The Success Fee will be payable at the point when payments are exchanged between you and the third-party organisation.

If we execute an agreement with a third party but the agreement collapses before any payments are exchanged do we still have to pay the Success Fee?
No, under these circumstances there would be no Success Fee applicable because no payments would have been exchanged between you and the third party. At this stage we would be happy to work with you to identify alternative partners with whom you can work.

To what elements of the agreement would the Success Fee be applicable?
The Success Fee would be applicable to all elements contained in the agreement where payments would be exchanged.

These would include, but not be limited to, any up-front payments, milestones and ongoing royalty payments for transactions through the partnering.

Check now!

Transaction value
million USD
Partnering Search
Profiling
Submit
The Success Fee
$320,000 (3.2%)

Number in the brackets shows percentage of the Success Fee to overall transaction value.

Contact us

For further information contact our team on +44 1904 520460, via email or request a callback.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us

(website) 38 queries took 310 ms
NrQueryErrorAffectedNum. rowsTook (ms)
1DESCRIBE `sites`551
2DESCRIBE `user`24242
3DESCRIBE `condet`17175
4DESCRIBE `countrycode`4422
5DESCRIBE `company`27272
6DESCRIBE `person`151514
7DESCRIBE `account`292917
8DESCRIBE `product_legacy`668
9DESCRIBE `sales_people`669
10DESCRIBE `profile`14148
11DESCRIBE `currencies`771
12DESCRIBE `update_rec`776
13DESCRIBE `dms_companies`262628
14DESCRIBE `dms_releases`101016
15DESCRIBE `dms_categories`449
16DESCRIBE `dms_clinical_areas`440
17DESCRIBE `dms_categories_dms_releases`221
18DESCRIBE `dms_clinical_areas_dms_releases`221
19DESCRIBE `dms_releases_sites`5514
20DESCRIBE `licopp`23236
21DESCRIBE `development_statuses`5517
22DESCRIBE `category`141418
23DESCRIBE `categories_sites`558
24DESCRIBE `categorisation`888
25DESCRIBE `licopps_sites`339
26DESCRIBE `service`151512
27DESCRIBE `enquiry`14141
28DESCRIBE `module_types`661
29DESCRIBE `press_release`13134
30DESCRIBE `press_releases_sites`559
31DESCRIBE `story`12125
32DESCRIBE `sites_stories`559
33DESCRIBE `story_assoc`446
34DESCRIBE `companies_sites`332
35DESCRIBE `categories_users`229
36DESCRIBE `authority`336
37DESCRIBE `sites_users`558
38SELECT `Site`.`id`, `Site`.`name`, `Site`.`email_domain`, `Site`.`short_name`, `Site`.`brand` FROM `sites` AS `Site` WHERE `Site`.`id` = 1 LIMIT 1118